P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. The company ...
Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer
Est. EPS $-3.96 · Revenue $385.15M · 2 analysts
Est. EPS $-5.62 · Revenue $393.35M · 1 analysts
Est. EPS $-7.27 · Revenue $1.55B · 1 analysts
Est. EPS $0.00 · Revenue $400.30M
| Metric | Latest | YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength. | QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes. |
|---|---|---|---|
| RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three). | $1.5B | -2.8% | -0.0% |
| Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day. | $-147.9M | -8.9% | +508.7% |
| Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials. | -9.9% | -109.9% | +193.6% |
| Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on). | -18.5% | +11.1% | +400.5% |
| Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales. | -10.1% | -12.0% | +508.7% |
| Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock. | $-91.2M | +17.2% | -125.4% |
| FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine. | -6.3% | +14.8% | -125.4% |
| Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe. | -183.5% | -183.9% | +516.0% |
| Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking. | 0.24x | -34.2% | +40.8% |
| Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground. | $656.6M | -16.2% | -2.9% |
| Metric | Annual (A vs E) | Annual Surprise | Quarter (A vs E) | Quarter Surprise |
|---|---|---|---|---|
| EPS Surprise | -45.26 vs -29.98 | -51.0% | -0.63 vs -1.90 | +66.8% |
| Revenue Surprise | $1.5B vs $1.4B | +2.2% | $386.4M vs $377.8M | +2.3% |
| Date | Executive | Title | Security | Side | Shares | Price |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | Hudson Vegas Investment SPV, LLC | 10 percent owner | Class V Common Stock | D | 100,000 | — |
| Aug 13, 2026 | Hudson Vegas Investment SPV, LLC | 10 percent owner | P3 LLC Unit | D | 100,000 | — |
| Aug 13, 2026 | Hudson Vegas Investment SPV, LLC | 10 percent owner | Class A Common Stock | A | 100,000 | — |
| Aug 10, 2026 | Hudson Vegas Investment SPV, LLC | 10 percent owner | Class A Common Stock | D | 1,041 | $13.38 |
| Aug 10, 2026 | Hudson Vegas Investment SPV, LLC | 10 percent owner | Class A Common Stock | D | 19,074 | $16.05 |
Operator: Good day, and welcome to the P3 Health Partners Second Quarter 26 Earnings Conference Call. All participants will be in a listen-only mode. By pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press *1 on your touch tone phone. And to withdraw your question, please press *2. Please note this event is being recorded. I would now like to turn the conference over to Mr. William Hoover of Investor Relations. Please go ahead. Thank you, operator, and thank you for joining us today. Before we proceed with the call, I would like to remind everyone that certain statements made during the call are forward-looking statements under the U.S. Federal Securities Laws. Including statements regarding our financial outlook and long term targets. These forward looking statements are only predictions and are based largely on our current expectations and projections about future events and financial trends. That we believe may affect our business and financial condition, and results of operations. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. Additional information concerning factors that could cause actual results to differ from statements made on this call is contained in a periodic report filed with the SEC. The forward looking statements made during this call speak only as of the date hereof, and the company undertakes no obligation to update or revise these forward looking statements. We refer to certain non-GAAP financial measures on this call, including adjusted operating expense, adjusted EBITDA, adjusted EBITDA per member per month, normalized adjusted EBITDA, medical margin, medical margin per member per month, and cash flow. These non GAAP financial measures are in addition to and not a substitute for or superior to the measures of financial performance prepared in accordance with GAAP. There are a number of limitations related to the use of these non GAAP financial measures. For example, other companies may calculate similarly titled non GAAP financial measures differently. Please refer to the appendix of our earnings release for a reconciliation of these non GAAP financial measures to the most direct comparable GAAP measures. The information presented on this call is contained in the press release that we issued today and in our SEC filings. Which may be accessed from the Investor page of the P3 Health Partners website. I will now turn the call over to Aric Coffman, CEO of P3 Health Partners. Aric Coffman: Good afternoon, and thank you for joining us today to discuss our second quarter results. Q2 represents a continuation of the positive momentum we have built over the last 2 years and reflects sustained execution against the plan we shared with you at the outset of my tenure. None of this happens without the work of our teams across the …
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
Aric Coffman | Chief Executive Officer, President & Director | USD 750,000 | — | 1974 | Active |
Amir Bacchus | Co-Founder, Chief Medical Officer & Director | USD 600,000 | — | 1965 | Active |
Leif Pedersen | Chief Financial Officer | USD 461,662 | Male | 1976 | Active |
Devery Goodey | Senior Vice President of Technology | — | Male | — | Active |
Todd Smith | Chief Legal Officer, Chief Compliance Officer & Corporate Secretary | — | Male | — | Active |
William Bettermann | Executive Vice President & Chief Operating Officer | — | Male | — | Active |
Erin Mastagni | Market President of Oregon | — | Female | — | Active |
Shelly Martin | Regional President of Nevada & Arizona | — | Female | — | Active |
Kassi Belz | Executive Vice President of Marketing & Communications | — | Female | — | Active |
Sarah Bussmann CRNI | Chief Administrative Officer | — | Female | — | Active |
P3 Health Partners NASDAQ: PIII reported second-quarter adjusted EBITDA of $54 million and raised its full-year 2026 outlook, while noting that the quarterly result included $45 million of favorable payer settlements and prior-year development.
P3 Health Partners Inc. (PIII) Q2 2026 Earnings Call Transcript
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ended June 30, 2026. "Q2 demonstrates that the business is now executing according to our plan. We delivered $54 million of adjusted EBITDA, with the core business driving improved profitability quarter over quarter. Our results reflect the structural improvements.
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for second quarter 2026 on Monday, August 10, 2026. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health Second Quarter 2026 Earnings C.
